Anxiety and depression in patients with Philadelphia-negative myeloproliferative neoplasms: a nationwide population-based survey in Denmark

References

• CampbellPJGreenARThe myeloproliferative disordersN Engl J Med2006355232452246617151367
   PubMed Web of Science ®Google Scholar
• ArberDAOraziAHasserjianRThe 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemiaBlood2016127202391240527069254
   PubMed Web of Science ®Google Scholar
• GeyerHLMesaRATherapy for myeloproliferative neoplasms: when, which agent, and how?Blood2014124243529353725472969
   PubMed Web of Science ®Google Scholar
• MesaRMillerCBThyneMMyeloproliferative neoplasms (MPNs) have a significant impact on patients’ overall health and productivity: the MPN Landmark surveyBMC Cancer20161616726922064
   PubMed Web of Science ®Google Scholar
• GeyerHLAndreassonBKosiorekHEThe role of sexuality symptoms in myeloproliferative neoplasm symptom burden and quality of life: An analysis by the MPN QOL International Study GroupCancer2016122121888189627070130
   PubMed Web of Science ®Google Scholar
• ScherberRMKosiorekHESenyakZComprehensively understanding fatigue in patients with myeloproliferative neoplasmsCancer2016122347748526670597
   PubMed Web of Science ®Google Scholar
• AndersonLAJamesGDuncombeASMyeloproliferative neoplasm patient symptom burden and quality of life: evidence of significant impairment compared to controlsAm J Hematol2015901086487026113113
   PubMed Web of Science ®Google Scholar
• AbelssonJAndréassonBSamuelssonJPatients with polycythemia vera have worst impairment of quality of life among patients with newly diagnosed myeloproliferative neoplasmsLeuk Lymphoma201354102226223023398206
   PubMed Web of Science ®Google Scholar
• ScherberRDueckACJohanssonPThe Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): international prospective validation and reliability trial in 402 patientsBlood2011118240140821536863
   PubMed Web of Science ®Google Scholar
• TefferiAGuglielmelliPLarsonDRLong-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosisBlood2014124162507251325037629
   PubMed Web of Science ®Google Scholar
• HultcrantzMKristinssonSYAnderssonTMPatterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: a population-based studyJ Clin Oncol201230242995300122802311
   PubMed Web of Science ®Google Scholar
• McfarlandDCPolizziHMascarenhasJKremyanskayaMHollandJHoffmanRPsychological Symptoms Among Patients With BCR-ABL-Negative Myeloproliferative NeoplasmsJ Natl Compr Canc Netw201614121563157027956541
   PubMed Web of Science ®Google Scholar
• ErlangsenAFedyszynIDanish nationwide registers for public health and health-related researchScand J Public Health201543433333925759376
   PubMed Web of Science ®Google Scholar
• SchmidtMSchmidtSASandegaardJLEhrensteinVPedersenLSørensenHTThe Danish National Patient Registry: a review of content, data quality, and research potentialClin Epidemiol2015744949026604824
   PubMed Web of Science ®Google Scholar
• SchmidtMPedersenLSørensenHTThe Danish Civil Registration System as a tool in epidemiologyEur J Epidemiol201429854154924965263
   PubMed Web of Science ®Google Scholar
• BrochmannNFlachsEMChristensenAIA nationwide population-based cross-sectional survey of health-related quality of life in patients with myeloproliferative neoplasms in Denmark (MPNhealthSurvey): survey design and characteristics of respondents and nonrespondentsClin Epidemiol2017914115028280390
   PubMed Web of Science ®Google Scholar
• ChristensenAIEkholmOGlümerCThe Danish National Health Survey 2010. Study design and respondent characteristicsScand J Public Health201240439139722786925
   PubMed Web of Science ®Google Scholar
• MatthiessenJBiltoft-JensenARasmussenLBHelsOFagtSGrothMVComparison of the Danish Physical Activity Questionnaire with a validated position and motion instrumentEur J Epidemiol200823531132218270796
   PubMed Web of Science ®Google Scholar
• EkholmOStrandberg-LarsenKChristensenKGrønbaekMComparison of assessment methods for self-reported alcohol consumption in health interview surveysEur J Clin Nutr200862228629117375115
   PubMed Web of Science ®Google Scholar
• ZierauFHardtFHenriksenJHValidation of a self-administered modified CAGE test (CAGE-C) in a somatic hospital ward: comparison with biochemical markersScand J Clin Lab Invest200565761562216271993
   PubMed Web of Science ®Google Scholar
• CharlsonMEPompeiPAlesKLMackenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis19874053733833558716
   PubMedGoogle Scholar
• ZigmondASSnaithRPThe hospital anxiety and depression scaleActa Psychiatr Scand19836763613706880820
   PubMed Web of Science ®Google Scholar
• SnaithRPZigmondASThe Hospital Anxiety and Depression Scale ManualLondonGL Assessments1994
   Google Scholar
• MooreySGreerSWatsonMThe factor structure and factor stability of the hospital anxiety and depression scale in patients with cancerBr J Psychiatry19911582552591812841
   PubMed Web of Science ®Google Scholar
• MendozaTRWangXSCleelandCSThe rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue InventoryCancer1999851511861196
   Web of Science ®Google Scholar
• EmanuelRMDueckACGeyerHLMyeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNsJ Clin Oncol201230334098410323071245
   PubMed Web of Science ®Google Scholar
• AaronsonNKAhmedzaiSBergmanBThe European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncologyJ Natl Cancer Inst19938553653768433390
   PubMed Web of Science ®Google Scholar
• EmanuelRMDueckACGeyerHLMyeloproliferative (MPN) Symptom Burden Response Thresholds: Assessment Of MPN-SAF TSS Quartiles As Potential Markers Of Symptom ResponseBlood American Society of Hematology Annual Meeting Abstracts20131224067
   Google Scholar
• The National Committee on Health Research EthicsGuidelines Available from: www.dnvk.dk/CVK/Home/English.aspxAccessed January 10, 2018
   Google Scholar
• MitchellAJFergusonDWGillJPaulJSymondsPDepression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysisLancet Oncol201314872173223759376
   PubMed Web of Science ®Google Scholar
• MitchellAJChanMBhattiHPrevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studiesLancet Oncol201112216017421251875
   PubMed Web of Science ®Google Scholar
• DjukanovicICarlssonJÅrestedtKIs the Hospital Anxiety and Depression Scale (HADS) a valid measure in a general population 65-80 years old? A psychometric evaluation studyHealth Qual Life Outcomes201715119328978356
   PubMed Web of Science ®Google Scholar
• HartungTJFriedrichMJohansenCThe Hospital Anxiety and Depression Scale (HADS) and the 9-item Patient Health Questionnaire (PHQ-9) as screening instruments for depression in patients with cancerCancer2017123214236424328654189
   PubMed Web of Science ®Google Scholar
• MesaRAMillerCBThyneMDifferences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark surveyCancer2017123344945827690182
   PubMed Web of Science ®Google Scholar